Literature DB >> 17286762

Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology.

C M Cale1, L Morton, D Goldblatt.   

Abstract

The objective of this study was to determine the utility of anti-nuclear antibody (ANA) testing in the investigation of cutaneous and other lupus symptoms in female carriers of X-linked chronic granulomatous disease (CGD). We undertook a prospective study of 19 carrier mothers attending our institution, with direct questioning of carriers concerning symptoms and testing for anti-nuclear and anti-phospholipid antibodies. A total of 58% reported significant photosensitive skin rashes, 42% reported mouth ulcers and 37% complained of joint pains that could not be attributed to other known causes. Anti-nuclear antibody (ANA) testing was negative in 73% of all carriers. The five positive ANAs were of low titre (maximum 1 : 320 on Hep 2 cells in two women) and only one weak positive double-stranded DNA antibody and no extractable nuclear antibodies were found. Several of the mothers, despite negative serology, benefited from referral to a specialist, and in some cases to specific treatment. A history of skin rashes, joint pain, fatigue and mouth ulcers should be sought actively in the female relatives of X-CGD patients but negative lupus serology should not preclude referral to appropriate dermatology or rheumatology services. as symptoms may respond well to appropriate treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286762      PMCID: PMC1868856          DOI: 10.1111/j.1365-2249.2007.03321.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  Chronic granulomatous disease.

Authors:  D Goldblatt; A J Thrasher
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

Review 2.  Lupus erythematosus-like lesions in a carrier of X-linked chronic granulomatous disease.

Authors:  S Córdoba-Guijarro; C Feal; E Daudén; J Fraga; A García-Díez
Journal:  J Eur Acad Dermatol Venereol       Date:  2000-09       Impact factor: 6.166

3.  Fatal granulomatous disease of childhood and benign lymphocytic infiltration of the skin (congenital dysphagocytosis).

Authors:  P S Macfarlane; A L Speirs; R G Sommerville
Journal:  Lancet       Date:  1967-02-25       Impact factor: 79.321

4.  Chronic granulomatous disease: quantitative clinicopathological relationships.

Authors:  E N Thompson; J F Soothill
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

5.  Lupus erythematosus associated with genetically determined deficiency of the second component of the complement.

Authors:  D M Lipsker; C Schreckenberg-Gilliot; B Uring-Lambert; A Meyer; D Hartmann; E M Grosshans; G Hauptmann
Journal:  Arch Dermatol       Date:  2000-12

6.  Chronic granulomatous disease. Report on a national registry of 368 patients.

Authors:  J A Winkelstein; M C Marino; R B Johnston; J Boyle; J Curnutte; J I Gallin; H L Malech; S M Holland; H Ochs; P Quie; R H Buckley; C B Foster; S J Chanock; H Dickler
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

Review 7.  The dermatosis of chronic granulomatous disease.

Authors:  M M Chowdhury; A Anstey; C N Matthews
Journal:  Clin Exp Dermatol       Date:  2000-05       Impact factor: 3.470

Review 8.  Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous disease.

Authors:  R A Rupec; T Petropoulou; B H Belohradsky; M Walchner; J G Liese; G Plewing; G Messer
Journal:  Eur J Dermatol       Date:  2000 Apr-May       Impact factor: 3.328

9.  Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD).

Authors:  Joanne R Brown; David Goldblatt; Joanna Buddle; Louise Morton; Adrian J Thrasher
Journal:  J Leukoc Biol       Date:  2003-05       Impact factor: 4.962

Review 10.  Current treatment options for chronic granulomatous disease.

Authors:  David Goldblatt
Journal:  Expert Opin Pharmacother       Date:  2002-07       Impact factor: 3.889

View more
  45 in total

Review 1.  Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves.

Authors:  Katharine S Nelson; David B Lewis
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

Review 2.  At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases.

Authors:  Peter C Grayson; Mariana J Kaplan
Journal:  J Leukoc Biol       Date:  2015-10-02       Impact factor: 4.962

3.  Chronic granulomatous disease.

Authors:  Lorenzo Loffredo
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

Review 4.  How neutrophil extracellular traps orchestrate the local immune response in gout.

Authors:  Christian Maueröder; Deborah Kienhöfer; Jonas Hahn; Christine Schauer; Bernhard Manger; Georg Schett; Martin Herrmann; Markus H Hoffmann
Journal:  J Mol Med (Berl)       Date:  2015-05-24       Impact factor: 4.599

Review 5.  Inflammatory consequences of inherited disorders affecting neutrophil function.

Authors:  Mary C Dinauer
Journal:  Blood       Date:  2019-03-21       Impact factor: 22.113

6.  Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase.

Authors:  Chaim O Jacob; Miriam Eisenstein; Mary C Dinauer; Wenyu Ming; Qiang Liu; Sutha John; Francesco P Quismorio; Andreas Reiff; Barry L Myones; Kenneth M Kaufman; Deborah McCurdy; John B Harley; Earl Silverman; Robert P Kimberly; Timothy J Vyse; Patrick M Gaffney; Kathy L Moser; Marisa Klein-Gitelman; Linda Wagner-Weiner; Carl D Langefeld; Don L Armstrong; Raphael Zidovetzki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

7.  Lupus and proliferative nephritis are PAD4 independent in murine models.

Authors:  Rachael A Gordon; Jan M Herter; Florencia Rosetti; Allison M Campbell; Hiroshi Nishi; Michael Kashgarian; Sheldon I Bastacky; Anthony Marinov; Kevin M Nickerson; Tanya N Mayadas; Mark J Shlomchik
Journal:  JCI Insight       Date:  2017-05-18

8.  Recurrent erythematous plaques on sun-exposed sites in an African American boy with chronic granulomatous disease.

Authors:  Mamina M Turegano; Chyi-Chia R Lee; Harry L Malech; Suk S De Ravin; Edward W Cowen; Isaac Brownell
Journal:  J Am Acad Dermatol       Date:  2014-03       Impact factor: 11.527

9.  Chronic granulomatous disease as a risk factor for autoimmune disease.

Authors:  Suk See De Ravin; Nora Naumann; Edward W Cowen; Julia Friend; Dianne Hilligoss; Martha Marquesen; James E Balow; Karyl S Barron; Maria L Turner; John I Gallin; Harry L Malech
Journal:  J Allergy Clin Immunol       Date:  2008-09-26       Impact factor: 10.793

Review 10.  Autoimmunity in immunodeficiency.

Authors:  Krista Todoric; Jessica B Koontz; Daniel Mattox; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.